Safety, Efficacy, and Ill Intent: Examining COVID-19 Vaccine Perceptions among the New Undervaccinated Moveable Middle in a U.S. Cohort, October 2022.
Safety, Efficacy, and Ill Intent: Examining COVID-19 Vaccine Perceptions among the New Undervaccinated Moveable Middle in a U.S. Cohort, October 2022.
复制标题
DOI：
10.3390/vaccines11111665
复制
发表时间：
2023-10-31
期刊：
影响因子：
7.8
通讯作者：
Nash D
中科院分区：
文献类型：
--
作者：
Piltch-Loeb R;Penrose K;Stanton E;Parcesepe AM;Shen Y;Fleary SA;Nash D
仅接种了初级疫苗系列（没有后续加强疫苗）的个人可能是一种新型的“可移动中间”，因为他们接受了最初的COVID-19疫苗接种。可能需要量身定制干预措施的可移动中间人群中的一个人群是患有常见精神障碍（CMD）的人。本文的目的是了解这一新的可移动中间人群（未接种疫苗者）以及未接种疫苗者对疫苗的看法，以检查有和无CMD症状者对COVID-19疫苗的看法和动机的差异程度。使用来自CHASING COVID队列的数据，我们研究了疫苗接种状况，CMD和疫苗接种不足者的疫苗感知之间的关系。在510名已完成初级疫苗系列但未加强接种的参与者中，疫苗接种不足的最常见原因集中在有效性上（不需要额外剂量，42.4%;没有足够的证据表明加强剂量有效，26.5%;已经患有COVID-19，19.6%）。其他的担忧与安全性（长期副作用，21.0%;短期副作用，17.6%）和后勤（计划获得助推器，但还没有时间，18.8%）有关。总体而言，疫苗接种不足人群最大的疫苗问题（超过30%）集中在有效性和安全性问题上。在调整后的模型中，抑郁或焦虑症状与疫苗有效性水平较低和安全性问题较大相关。我们研究的意义是，希望最大限度地提高疫苗接种率的运动应该考虑关注和强调有关有效性和安全性问题的信息。
Individuals who received their primary vaccine series only (with no subsequent booster) may be a new type of “moveable middle” given their receipt of the original COVID-19 vaccination. One population within the moveable middle for whom tailored interventions may be needed is individuals with common mental disorders (CMD). The purpose of this paper is to understand the vaccine perceptions among this new moveable middle—the undervaccinated—and within the undervaccinated to examine the extent to which COVID-19 vaccine perceptions and motivations differ among those with and without symptoms of CMD. Using data from the CHASING COVID Cohort, we examine the relationship between vaccination status, CMD, and vaccine perceptions in the undervaccinated. Among 510 undervaccinated participants who had completed the primary vaccine series but were not boosted, the most common reasons for undervaccination focused on efficacy (not seeing a need for an additional dose, 42.4%; there not being enough evidence that a booster dose is effective, 26.5%; already having had COVID-19, 19.6%). Other concerns were related to safety (long-term side effects, 21.0%; short-term side effects, 17.6%) and logistics (plan to get a booster but haven’t had time yet, 18.8%). Overall, the greatest vaccine concerns (over 30%) for the undervaccinated focused on efficacy and safety issues. Symptoms of depression or anxiety were associated with lower levels of vaccine efficacy and greater safety concerns in adjusted models. The implications of our study are that campaigns that are hoping to maximize vaccination uptake should consider focusing on and emphasizing messaging on efficacy and safety issues.
登录
查看更多内容
影响因子：
2.9
作者：
Robertson MM;Kulkarni SG;Rane M;Kochhar S;Berry A;Chang M;Mirzayi C;You W;Maroko A;Zimba R;Westmoreland D;Grov C;Parcesepe AM;Waldron L;Nash D;CHASING COVID Cohort Study Team
通讯作者：
CHASING COVID Cohort Study Team
DOI：
10.1073/pnas.2211132120
发表时间：
2023-01-17
影响因子：
11.1
作者：
通讯作者：
--
影响因子：
3.7
作者：
通讯作者：
--
DOI：
10.1016/s2215-0366(21)00232-7
发表时间：
2021-09
期刊：
The lancet. Psychiatry
影响因子：
--
作者：
Vai B;Mazza MG;Delli Colli C;Foiselle M;Allen B;Benedetti F;Borsini A;Casanova Dias M;Tamouza R;Leboyer M;Benros ME;Branchi I;Fusar-Poli P;De Picker LJ
通讯作者：
De Picker LJ
DOI：
10.1002/wps.20806
发表时间：
2021-03
期刊：
World psychiatry : official journal of the World Psychiatric Association (WPA)
影响因子：
--
作者：
Wang Q;Xu R;Volkow ND
通讯作者：
Volkow ND